BDBM50196208 1-[2-[(2,1,3-benzothiadiazol-5-ylsulfonyl)amino]-4-bromobenzoyl]-piperidine::CHEMBL387299::N-(5-bromo-2-(piperidine-1-carbonyl)phenyl)benzo[c][1,2,5]thiadiazole-5-sulfonamide

SMILES Brc1ccc(C(=O)N2CCCCC2)c(NS(=O)(=O)c2ccc3nsnc3c2)c1

InChI Key InChIKey=NXOJBHPTOAAHMH-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50196208   

TargetGastrin/cholecystokinin type B receptor(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196208(N-(5-bromo-2-(piperidine-1-carbonyl)phenyl)benzo[c...)
Affinity DataKi:  5.01E+3nMAssay Description:Displacement of [125I]CCK-8S from CCK2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50196208(N-(5-bromo-2-(piperidine-1-carbonyl)phenyl)benzo[c...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [125I]CCK-8S from human CCK1RMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed